Protagenic Therapeutics, Inc.\new Selling and Marketing Expense
Protagenic Therapeutics, Inc.\new (PTIX) reported Selling and Marketing Expense of $793.00 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2011-11-14
- Protagenic Therapeutics, Inc.\new selling and marketing expense for the quarter ending 2011-09-30 was $793.00K, a 15.46% decline year-over-year.
- Protagenic Therapeutics, Inc.\new selling and marketing expense for the quarter ending 2011-06-30 was $1.07M, a 19.60% decline year-over-year.
- Protagenic Therapeutics, Inc.\new selling and marketing expense for the quarter ending 2010-09-30 was $938.00K.
- Protagenic Therapeutics, Inc.\new selling and marketing expense for the quarter ending 2010-06-30 was $1.34M.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month |
|---|---|---|---|
| 2011-09-30 | $793.00K 10-Q · filed 2011-11-14 | $1.87M derived: sum of 2 quarters · filed 2011-11-14 | $2.91M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $1.07M 10-Q/A · filed 2011-09-07 | $2.12M 10-Q/A · filed 2011-09-07 | |
| 2010-09-30 | $938.00K 10-Q · filed 2011-11-14 | $2.27M derived: sum of 2 quarters · filed 2011-11-14 | $3.23M 10-Q · filed 2011-11-14 |
| 2010-06-30 | $1.34M 10-Q/A · filed 2011-09-07 | $2.29M 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |